Condias Combi 50 mg/850 mg filmom obložene tablete
| Name | Condias Combi 50 mg/850 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-769185706 |
| Active Substance | sitagliptinklorid hidrat metforminklorid |
| Composition | jedna tableta sadrži sitagliptinklorid hidrat što odgovara 50 mg sitagliptina i 850 mg metforminklorida |
| Pharmaceutical Form | Filmom obložena tableta |
| Manufacturer | Belupo lijekovi i kozmetika d.d., Koprivnica, Hrvatska |
| Marketing Authorisation Holder | Belupo lijekovi i kozmetika d.d., Ulica Danica 5, Koprivnica, Hrvatska |
| Marketing Authorisation Date | 25.05.2023 |
| MA Period of Validity | 25.05.2028 |
| Classification Number | UP/I-530-09/22-01/86 |
| Registration Number | 381-12-01/70-23-10 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ponovljivi recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | A10BD07 |
| Marketing status | nije stavljeno u promet |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
